Efficacy and Safety of Metformin Versus Empagliflozin on Chronic Kidney Disease Progression

NCT05373680 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

118

Enrollment

OTHER

Sponsor class

Conditions

Renal Insufficiency, Chronic

Interventions

DRUG: Metformin
DRUG: Empagliflozin
OTHER: Control

Sponsor

Tanta University

Collaborators

[object Object]